Cargando…

Patient-derived organoids: a promising model for personalized cancer treatment

Detalles Bibliográficos
Autores principales:	Yang, Huayu, Sun, Lejia, Liu, Meixi, Mao, Yilei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225812/ https://www.ncbi.nlm.nih.gov/pubmed/30430011 http://dx.doi.org/10.1093/gastro/goy040

Ejemplares similares

Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis
por: Yang, Huayu, et al.
Publicado: (2019)

Study on drug screening multicellular model for colorectal cancer constructed by three-dimensional bioprinting technology
por: Wang, Peipei, et al.
Publicado: (2023)

Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering
por: Sun, Hang, et al.
Publicado: (2023)

High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China
por: Sun, Lejia, et al.
Publicado: (2020)

Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy
por: Wang, Yanan, et al.
Publicado: (2022)

Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening
por: Yuan, Bo, et al.
Publicado: (2022)

Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria
por: Xu, Wei, et al.
Publicado: (2017)

Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine
por: Gilazieva, Zarema, et al.
Publicado: (2020)

The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
por: Bae, JuneSung, et al.
Publicado: (2022)

Engineering organoids: a promising platform to understand biology and treat diseases
por: Aqeilan, Rami I.
Publicado: (2020)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

Quantitative definitions of prognostic indicators of resectable pancreatic cancer
por: Sun, Hang, et al.
Publicado: (2022)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
por: Yu, Ya-ya, et al.
Publicado: (2022)

Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
por: Colella, Gianluca, et al.
Publicado: (2018)

Application of Patient-Derived Cancer Organoids to Personalized Medicine
por: Shiihara, Masahiro, et al.
Publicado: (2022)

EUS-guided fine-needle technique-derived cancer organoids: A tailored “Shennong deity” for every patient with cancer
por: Yang, Fan, et al.
Publicado: (2019)

Advances of Patient-Derived Organoids in Personalized Radiotherapy
por: Wang, Yuenan, et al.
Publicado: (2022)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer
por: Huang, Hua, et al.
Publicado: (2023)

Revolutionizing preclinical research for pancreatic cancer: the potential of 3D bioprinting technology for personalized therapy
por: Sun, Hang, et al.
Publicado: (2023)

Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers
por: Sun, Lejia, et al.
Publicado: (2021)

Islet organoid as a promising model for diabetes
por: Zhang, Xiaofei, et al.
Publicado: (2021)

Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection
por: Sun, Lejia, et al.
Publicado: (2021)

Standard: Human intestinal cancer organoids
por: Lin, Hanqing, et al.
Publicado: (2023)

Kidney organoids for disease modeling
por: Garreta, Elena, et al.
Publicado: (2018)

Patient-Derived Organoids as a Promising Tool for Multimodal Management of Sarcomas
por: Xu, Songfeng, et al.
Publicado: (2023)

Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment
por: Vivarelli, Silvia, et al.
Publicado: (2020)

Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma
por: Ramzy, George M., et al.
Publicado: (2023)

Stem Cell Derived Organoids in Human Disease and Development
por: Liebau, Stefan, et al.
Publicado: (2019)

Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience
por: Sun, Lejia, et al.
Publicado: (2020)

Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival
por: Sun, Lejia, et al.
Publicado: (2021)

Head and neck cancer organoids as a promising tool for personalized cancer therapy: A literature review
por: Mohtasham, Nooshin, et al.
Publicado: (2022)

Subharmonic scattering of ultrasound contrast agent microbubbles may be an effective and promising tool for portal vein pressure estimation
por: Pang, Mingchang, et al.
Publicado: (2023)

Patient‐derived renal cell carcinoma organoids for personalized cancer therapy
por: Li, Zhichao, et al.
Publicado: (2022)

Cardiac organoid — a promising perspective of preclinical model
por: Zhao, Dandan, et al.
Publicado: (2021)

Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
por: Chen, Ping, et al.
Publicado: (2021)

The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
por: Granat, Lauren M., et al.
Publicado: (2019)

Kidney organoids as a promising tool in nephrology
por: Wu, Mengyuan, et al.
Publicado: (2021)

Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine
por: Kiwaki, Takumi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tq75hmtntgduievmgu6qt5hisn